What every intensivist needs to know about antimicrobial dosing in patients on ECMO, RRT and plasmapheresis
- 11 August 2026
- journal article
- Published by Elsevier in Journal of Critical Care
- Vol. 96
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- How to perform pharmacokinetic research of antimicrobial drugs in critically ill patients undergoing continuous renal replacement therapy: a scoping review of all relevant pharmacokinetic factorsClinical Microbiology and Infection, 2025
- Big Data Bayesian Truths: No Vancomycin Trough Concentration Target Is Sufficiently Precise for Safety or EfficacyOpen Forum Infectious Diseases, 2025
- Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing softwareIntensive Care Medicine, 2022
- Plasma exchange in the intensive care unit: a narrative reviewIntensive Care Medicine, 2022
- Impact of therapeutic plasma exchange on meropenem pharmacokineticsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2022
- Pharmacokinetics of Commonly Used Antimicrobials in Critically Ill Adults During Extracorporeal Membrane Oxygenation: A Systematic ReviewDrugs, 2021
- Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#Intensive Care Medicine, 2020
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutionsThe Lancet Infectious Diseases, 2014
- Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice AnymoreClinical Infectious Diseases, 2007
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998